Tired of living with a stuffy nose, postnasal drip, sinus infections, facial pain, poor sense of smell, and the other symptoms that come with nasal polyps? It’s time to seek treatment. “There are a ...

For severe chronic rhinosinusitis with nasal polyps, the novel monoclonal antibody stapokibart reduced symptoms and polyp size atop treatment with a daily intranasal corticosteroid. The polyp size ...

On Monday, GSK plc (NYSE:GSK) released headline results from the phase 3 trials ANCHOR-1 and ANCHOR-2, which assessed the efficacy and safety of depemokimab versus placebo in adults with chronic ...

These symptoms can affect nearly every aspect of your daily life, from sleeping to smelling and even breathing. Understandably, that can take a toll on your mental health as well. Here are some of the ...

A comparison of type 2 biologics indicated for the treatment of chronic rhinosinusitis with nasal polyps identified dupilumab as the most effective drug in decreasing nasal polyp score and nasal ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Prevalence of type 2 inflammation ranged from 64.2% to ...

Please provide your email address to receive an email when new articles are posted on . Three currently available type 2 biologics approved for asthma appeared effective in treating chronic ...

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a relapsing inflammatory disorder of the sinonasal mucosa characterised by polyp formation and persistent sinonasal symptoms. Predominantly driven ...

Nasal polyp development, treatment, and recurrence were topics up for discussion in this year’s most popular nasal polyps–related content. Nasal polyp development, treatment, and recurrence, as well ...

The first head-to-head randomized clinical trial to compare biologics in severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting asthma showed an advantage to dupilumab (Dupixent) over ...